Global Retirement Partners, LLC Abb Vie Inc. Transaction History

Global Retirement Partners, LLC

$3.25 Billion
Q3 2024

A detailed history of Global Retirement Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Global Retirement Partners, LLC holds 80,347 shares of ABBV stock, worth $14.5 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

80,347

Previous 81,503 1.42%

Holding current value

$14.5 Million

Previous $14 Million 13.5%

% of portfolio

0.49%

Previous 0.44%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$163.84 - $199.33 $189,399 - $230,425	-1,156 Reduced 1.42%	80,347 $15.9 Million
Q2 2024 Jul 23, 2024	BUY	$154.79 - $180.76 $1.12 Million - $1.31 Million	7,260 Added 9.78%	81,503 $14 Million
Q1 2024 Apr 23, 2024	SELL	$159.82 - $182.1 $23,014 - $26,222	-144 Reduced 0.19%	74,243 $13.5 Million
Q4 2023 Jan 18, 2024	BUY	$137.6 - $154.97 $223,462 - $251,671	1,624 Added 2.23%	74,387 $11.5 Million
Q3 2023 Oct 13, 2023	SELL	$133.59 - $154.65 $509,913 - $590,299	-3,817 Reduced 4.98%	72,763 $10.8 Million
Q2 2023 Jul 20, 2023	BUY	$132.51 - $164.9 $45,318 - $56,395	342 Added 0.45%	76,580 $10.3 Million
Q1 2023 May 05, 2023	BUY	$144.61 - $166.54 $6.3 Million - $7.25 Million	43,560 Added 133.3%	76,238 $12.2 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $706,764 - $847,595	5,110 Added 18.54%	32,678 $5.28 Million
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $310,293 - $355,886	2,312 Added 9.15%	27,568 $4.04 Million
Q2 2022 Jul 15, 2022	BUY	$137.62 - $174.96 $74,452 - $94,653	541 Added 2.19%	25,256 $3.87 Million
Q1 2022 Jul 14, 2022	BUY	$131.98 - $163.75 $3.26 Million - $4.05 Million	24,715 New	24,715 $3.69 Million
Q4 2021 Jan 21, 2022	SELL	$107.43 - $135.93 $2.24 Million - $2.84 Million	-20,883 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$106.4 - $120.78 $343,033 - $389,394	3,224 Added 18.26%	20,883 $2.25 Million
Q2 2021 Jul 15, 2021	SELL	$105.21 - $117.21 $26,302 - $29,302	-250 Reduced 1.4%	17,659 $1.99 Million
Q1 2021 Apr 14, 2021	SELL	$102.3 - $112.62 $62,709 - $69,036	-613 Reduced 3.31%	17,909 $1.94 Million
Q4 2020 Jan 13, 2021	BUY	$80.49 - $108.67 $284,049 - $383,496	3,529 Added 23.54%	18,522 $1.99 Million
Q3 2020 Oct 09, 2020	SELL	$85.91 - $100.83 $78,092 - $91,654	-909 Reduced 5.72%	14,993 $1.31 Million
Q2 2020 Jul 13, 2020	BUY	$73.37 - $98.18 $174,987 - $234,159	2,385 Added 17.64%	15,902 $1.56 Million
Q1 2020 Apr 28, 2020	SELL	$64.5 - $97.79 $47,665 - $72,266	-739 Reduced 5.18%	13,517 $1.03 Million
Q4 2019 Jan 23, 2020	SELL	$72.13 - $90.25 $3,317 - $4,151	-46 Reduced 0.32%	14,256 $1.26 Million
Q3 2019 Nov 19, 2019	BUY	$62.98 - $75.72 $161,732 - $194,448	2,568 Added 21.89%	14,302 $1.08 Million
Q2 2019 Nov 19, 2019	BUY	$65.7 - $83.98 $465,944 - $595,586	7,092 Added 152.78%	11,734 $853,000
Q1 2019 May 07, 2019	SELL	$77.14 - $90.79 $23,219 - $27,327	-301 Reduced 6.09%	4,642 $374,000
Q4 2018 Feb 22, 2019	BUY	$77.85 - $96.01 $32,385 - $39,940	416 Added 9.19%	4,943 $456,000
Q3 2018 Oct 17, 2018	SELL	$88.91 - $98.84 $7,824 - $8,697	-88 Reduced 1.91%	4,527 $428,000
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $628 - $743	-7 Reduced 0.15%	4,615 $428,000
Q1 2018 Aug 10, 2018	SELL	$92.01 - $123.21 $24,842 - $33,266	-270 Reduced 5.52%	4,622 $437,000
Q4 2017 Aug 13, 2018	BUY	$89.56 - $98.21 $36,271 - $39,775	405 Added 9.03%	4,892 $473,000
Q3 2017 Aug 10, 2018	BUY	$69.85 - $89.22 $75,996 - $97,071	1,088 Added 32.01%	4,487 $399,000
Q2 2017 Aug 10, 2018	BUY	N/A	780 Added 29.78%	3,399 $246,000
Q1 2017 Aug 10, 2018	SELL	N/A	-321 Reduced 10.92%	2,619 $171,000
Q4 2016 Aug 10, 2018	BUY	N/A	2,940	2,940 $184,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.

Account

Global Retirement Partners, LLC Abb Vie Inc. Transaction History